Siegfried has appointed Eduardo Montanha as Chief Operating Officer and a member of its Executive Committee, effective September 1, as the pharmaceutical CDMO advances its strategy to integrate operations across its global network.
The appointment follows the company's previously announced decision to merge its separate Chief Operating Officer roles for Drug Substances and Drug Products into a single leadership position.
The move is designed to strengthen Siegfried's end-to-end offering, bringing drug substance and drug product operations under one executive to improve coordination, efficiency and customer delivery across the pharmaceutical value chain.
Montanha joins Siegfried with more than two decades of international leadership experience in pharmaceutical and biopharmaceutical manufacturing. He most recently served as Executive Vice President, Head of Global Technical Operations & Quality at Fresenius Kabi, where he oversaw an integrated network of approximately 30 manufacturing sites across multiple regions.
Earlier in his career, he held senior leadership roles at Takeda, Sandoz, Hexal and Hoechst/Aventis, leading technical operations, quality, supply and large-scale manufacturing organizations.
In his new role, Montanha will be responsible for strengthening supply performance, improving operational efficiency and enhancing reliability across Siegfried's global manufacturing network as the company continues to expand its integrated CDMO capabilities.
He holds a bachelor's degree in chemical engineering, a postgraduate qualification in Industrial Automation and an MBA in Project Management. His career has included leadership assignments across Europe and Latin America.
Marcel Imwinkelried, Chief Executive Officer of Siegfried, welcomed the appointment, saying: “I am very pleased to welcome Eduardo to Siegfried. He brings outstanding global operations and quality leadership experience and will play an important role in further enhancing supply performance, operational efficiency and reliability for our customers.”
